APA
DFTX

American Portfolios Advisors’s Definium Therapeutics DFTX Stock Holding History

American Portfolios Advisors’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$7K Hold
2,000
– – ﹤0.01% 2671
2022
Q2 		$19.2K Hold
2,000
– – ﹤0.01% 2252
2022
Q1 		$33.3K Hold
2,000
– – ﹤0.01% 2092
2021
Q4 		$41.4K Hold
2,000
– – ﹤0.01% 1955
2021
Q3 		$69.9K Hold
2,000
– – ﹤0.01% 1608
2021
Q2 		$104K Buy
+2,000
New +$105K ﹤0.01% 1405

Other funds holding DFTX

DCI
Data Collective IV Palo Alto, California $55.9M AUM 49.14% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
BB
Busey Bank Urbana, Illinois $3.68B AUM 26.6% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

American Portfolios Advisors's DFTX Position: Q3 2022 in Review

American Portfolios Advisors held its Definium Therapeutics (DFTX) position steady in Q3 2022 at 2,000 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #2671.

American Portfolios Advisors first reported a position in DFTX in Q2 2021 and has held it in 6 quarters since. The position peaked at $104K in Q2 2021. 101 funds tracked by Wall St. Rank hold DFTX as of Q3 2022.

  • American Portfolios Advisors held 2,000 shares of Definium Therapeutics worth $7K as of Q3 2022.
  • American Portfolios Advisors left its Definium Therapeutics share count unchanged in Q3 2022.
  • Definium Therapeutics made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2671 holding.
  • American Portfolios Advisors first reported a position in Definium Therapeutics in Q2 2021 and has held it in 6 quarters since.
  • American Portfolios Advisors's Definium Therapeutics position peaked at $104K in Q2 2021.
  • 101 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.